A new study provides a powerful way to study infections in environments that closely mimic human organs. The strategy, tested ...

Primary effectiveness was measured by the number of patients with HIV-1 RNA ≥50 copies/mL at Week 48, as well as the number of patients with a change in CD4 cell count, and the proportion of patients ...

Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...

It was announced last month that the injection was approved for England and Wales and campaigners had called for NI to follow ...

A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.

As the first COVID-19 vaccines are rolled out around the world, HIV/AIDS experts and advocates have sought to reassure those ...

Researchers are increasingly developing antibody therapies to treat infectious diseases. Therapies are being designed to ...